In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
Movie Review: Radhey: Your Most Wanted Bhai
Screenplay and Dialogue: AC Mugil and Vijay M
A total of 19 members, including seven Trinamool Congress members, were on Tuesday suspended from
In the last 24 hours, 2 lakh 64 thousand 202 corona infections were found in the country. 1 lakh
There is a dental emergency in the UK. In waiting for the dentist, the condition of many people h
The 41st match of IPL 2024 was played on Thursday between Sunrisers Hyderabad and Royal Chal
Despite the decrease in corona cases in China, there has been talking about showing strictness by
Mukesh Ambani may have slipped from eighth place to ninth on the list of top billionaires, but on
Fiscal Deficit: The government got Rs 5.96 lakh crore from tax, and spent Rs 9.48 lakh crore
The fiscal deficit has increased to Rs 3.51 lakh crore in the first quarter of April-June. This i
Prime Minister Narendra Modi has flagged off Vande Bharat from Katra railway station to Srinagar.
India Coronavirus Updates: The corona epidemic crisis continues. Corona cases have increased for
